Anthropic IPO preparations moved into their most exposed phase this week, with chief executive Dario Amodei and other executives sitting down with prospective investors ahead of a listing targeted for September or early October. The company carries a $965B valuation, a mark that put it above OpenAI for the first time and that would make this the largest initial public offering ever completed. Morgan Stanley, Goldman Sachs and JPMorgan Chase are leading the work. The pitch is meeting three specific objections: cheaper Chinese systems gaining ground, friction with the Trump administration, and local opposition to new datacenter construction across the US. Anthropic’s counter is that most users gravitate toward the most capable system available, and that Chinese labs still trail by several months on capability. What follows is a question of timing as much as technology, because a valuation of this size leaves very little room for a soft reception.
The Read
- Anthropic is meeting investors ahead of a September or early October listing at a $965B valuation.
- That mark passed OpenAI for the first time and would rank as the largest IPO ever priced.
- Pushback centers on cheaper Chinese models, Trump administration friction and datacenter opposition.
Amodei Runs the Roadshow Before the Window Opens
The unusual part of this Anthropic IPO is who is doing the talking and when. Founders normally surface late in a listing process, once the banks have set the range and the story is fixed. Here the chief executive is in the room early, which reads as a company answering doubts rather than managing demand. That distinction sets the tone for everything the book does over the next few weeks.
The backdrop is a market that has already absorbed a heavy calendar. Issuers raised $227.5B through July 15, excluding blank-check vehicles, so the buy side is neither starved for paper nor desperate for a new AI name. A deal that would be the largest on record has to clear a bar set by everything that priced ahead of it this year.
Sequencing matters more than usual here. The bull view is that going first captures the entire pool of institutional AI allocation before a rival can compete for it. The bear view is that going first means discovering the clearing price on your own, with no comparable to anchor the book, which is exactly what happened when OpenAI pushed its own listing to 2027 after the SpaceX drop.
A September Window Compresses the Pricing Runway
The mechanics of the calendar are doing real work on this deal. A September or early October print leaves weeks, not months, to convert meetings into an order book, and the timing has already been described as subject to change. A moving date is a negotiating signal, since issuers hold flexibility precisely when demand has yet to firm up.
Confidential preparation cuts both ways in this setup. It lets an issuer stage disclosure and pick its moment, and it also means the market prices a company it has seen only through leaks and briefings. The same dynamic ran through the sector when a confidential S-1 heated up the listing race without giving anyone a set of audited numbers to work from.
One thing to notice is what the roadshow is actually defending. The objections raised are not about product quality or revenue trajectory, they are about competitive durability and political exposure. Those are multiple questions rather than earnings questions, and a multiple set at $965B before a single public print has to survive both.
Passing OpenAI on Valuation Buys a Scarcity Premium
The constructive case starts with position. The $965B mark passed OpenAI for the first time, and with its closest peer now looking at a listing as late as next year, public-market investors wanting direct frontier-lab exposure have exactly one route for the next several quarters. Scarcity is a valuation input whether or not it should be, and the Anthropic IPO is the only vehicle carrying it right now.
Demand for coding tools and model access is the operating support underneath that argument. The capability gap Anthropic points to is measured in months, and in enterprise procurement a lead measured in months decides renewals. Buyers who standardize on the strongest available system tend to stay put through at least one contract cycle, which is the closest thing to recurring revenue this sector currently offers.
Precedent supports the upside path when a marquee name arrives with genuine scarcity attached. The market absorbed size without difficulty when SpaceX priced a $1.75T Nasdaq debut at $135, and index-tracking demand added a bid that had nothing to do with fundamentals. A deal of this magnitude carries the same mechanical inflows if it clears.
Cheap Chinese Models and Datacenter Opposition Cap the Multiple
The downside case runs through price rather than capability. Lower-cost Chinese systems keep closing ground, DeepSeek may file as early as this year, and a rival that is merely adequate at a fraction of the cost changes the shape of the market well before it changes the leaderboard. A months-long lead is not a moat when the cheaper alternative clears the buyer’s threshold. That is the specific risk the Anthropic IPO has to price, and it is the one objection the roadshow cannot settle with a benchmark chart.
Political exposure is the second drag, and it is already documented. The Trump administration restricted foreign access to two leading models, and Anthropic has litigated against the Defense Department over supply chain concerns. An issuer heading into a record listing while in open friction with its own government is carrying a risk factor that institutional buyers price rather than ignore.
Datacenter opposition is the least discussed of the three and possibly the most structural. Local resistance to new construction across the US constrains the compute buildout that the entire valuation assumes, and permitting delays do not resolve on an earnings timetable. Capacity that arrives two years late reprices a growth curve immediately.
The cautionary comparison is recent and specific. A record valuation is no protection once the lockup and the index flows have run their course, as the market saw when SpaceX fell below its IPO price after entering the Nasdaq 100. The asymmetry an investor has to price here is narrow: the upside needs a September window that holds and a book built before any Chinese filing lands, while the downside needs only one quarter where the capability gap compresses and the scarcity premium goes with it.
More to come.
About the Author
